Related references
Note: Only part of the references are listed.A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells
Li Huayi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-B-dependent P-glycoprotein upregulation
Su-Fern Tan et al.
JOURNAL OF LIPID RESEARCH (2019)
TNF-α induces apoptosis of human nucleus pulposus cells via activating the TRIM14/NF-κB signalling pathway
Hao Zhu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
HIF-transcribed p53 chaperones HIF-1α
Esha Madan et al.
NUCLEIC ACIDS RESEARCH (2019)
The role of p53 in cancer drug resistance and targeted chemotherapy
Karin Hientz et al.
ONCOTARGET (2017)
iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding
Wenjie Ge et al.
CANCER CELL (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway
Jiong Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP (vol 23, pg 618, 2013)
Min Lu et al.
CANCER CELL (2016)
p53 in survival, death and metabolic health: a lifeguard with a licence to kill
Flore Kruiswijk et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
A pro-apoptotic function of iASPP by stabilizing p300 and CBP through inhibition of BRMS1 E3 ubiquitin ligase activity
D. Kramer et al.
CELL DEATH & DISEASE (2015)
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB
Ying Hu et al.
ONCOTARGET (2015)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Senescence and aging: the critical roles of p53
A. Rufini et al.
ONCOGENE (2013)
Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase
Xingwu Wang et al.
NATURE COMMUNICATIONS (2013)
The diverse and complex roles of NF-κB subunits in cancer
Neil D. Perkins
NATURE REVIEWS CANCER (2012)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-Hodgkin's lymphoma cells
T. Lwin et al.
LEUKEMIA (2007)
Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB
Wei-Chien Huang et al.
MOLECULAR CELL (2007)
Effects of IκBα and its mutants on NF-κB and p53 signaling pathways
Xian Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53
Daniele Bergamaschi et al.
NATURE GENETICS (2006)
Regulation of NF-κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
S Rocha et al.
EMBO JOURNAL (2005)
A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice
BJ Herron et al.
HUMAN MOLECULAR GENETICS (2005)
P53 stabilization is decreased upon NFκB activation:: A role for NFκB in acquisition of resistance to chemotherapy
V Tergaonkar et al.
CANCER CELL (2002)
In vitro comparative evaluation of trastuzumab (Herceptin (R)) combined with paclitaxel (Taxol (R)) or docetaxel (Taxotere (R)) in HER2-expressing human breast cancer cell lines
JL Merlin et al.
ANNALS OF ONCOLOGY (2002)
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2
A Ito et al.
EMBO JOURNAL (2001)
Role of NF-κB in p53-mediated programmed cell death
KM Ryan et al.
NATURE (2000)
Share Paper
